Current concepts in adult respiratory distress syndrome in children

G J Redding1

  • 1Pulmonary Medicine Division Department of Pediatrics, Children's Hospital and Regional Medical Center, Seattle, Washington 98105, USA. gredding@u.washington.edu

Insights

Acute respiratory distress syndrome (ARDS) in children is severe lung injury with high mortality. Advances in lung-protective ventilation and life support improve survival, but further interventions are needed for inflammation and fibrosis.

Area of Science:

  • Pediatric critical care medicine
  • Pulmonology
  • Intensive care medicine

Background:

  • Acute respiratory distress syndrome (ARDS) is a severe lung injury characterized by alveolar-capillary damage, leading to noncardiogenic pulmonary edema, neutrophilic alveolitis, and potentially pulmonary fibrosis.
  • Mortality in pediatric ARDS is high, especially with co-existing conditions, sepsis, or multi-organ failure.
  • While lung function may improve in survivors, persistent pulmonary fibrosis remains a concern.

Purpose of the Study:

  • To review current understanding and management strategies for pediatric Acute Respiratory Distress Syndrome (ARDS).
  • To highlight recent advances in critical care for children with ARDS.
  • To identify future research directions for improving ARDS outcomes.

Main Methods:

  • Review of current literature on pediatric ARDS pathophysiology and treatment.
  • Analysis of established and emerging therapeutic interventions.
  • Synthesis of evidence regarding lung-protective strategies and advanced support modalities.

Main Results:

  • Pediatric ARDS involves complex alveolar-capillary injury and inflammation.
  • Lung-protective ventilator strategies, permissive hypercapnia, inhaled nitric oxide, high-frequency ventilation, and extracorporeal life support are key advancements.
  • These interventions, particularly in combination, aim to mitigate ventilator-induced lung injury and improve survival.

Conclusions:

  • Current management of pediatric ARDS focuses on minimizing lung injury and supporting vital functions.
  • Future interventions should target reducing alveolar inflammation, enhancing fluid clearance, and preventing pulmonary fibrosis.
  • Continued research and multimodal treatment approaches are essential for improving survival and recovery in children with ARDS.

Related Concept Videos

Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...